Loading news...
Algert Global LLC raised its stake in shares of Cognex Corporation (NASDAQ: CGNX) by 73.3% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 165,337 shares of the scientific and technical instruments company's stock after buying an additional 69,950
Cognex (CGNX) reported earnings 30 days ago. What's next for the stock?
AI infrastructure stocks have rallied despite tech-sector headwinds. VRT, HUBS, DELL, KEYS and CGNX surged in the past month and carry favorable ranks signaling further upside.
VRT, HUBS, DELL, KEYS and CGNX have surged in the past month as AI-powered data-center, AI servers and AI software adoption drove growth and signaled upside.
Five surging mid-cap stocks, AROC, CENX, CGNX, FORM and IPGP, stand out in 2026 as the S&P 400 beats major indexes.
Cognex Corporation (NASDAQ: CGNX - Get Free Report) has received an average rating of "Moderate Buy" from the seventeen brokerages that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have given a strong buy recommendation to the company.
Citigroup Inc. decreased its position in Cognex Corporation (NASDAQ: CGNX) by 80.3% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 39,009 shares of the scientific and technical instruments company's stock after selling 158,866 shares during the quarter. Citigroup Inc.'s holdings
Cognex (NASDAQ: CGNX) CEO Robert Willett told investors the industrial machine vision company is positioning for renewed growth across its end markets, while pursuing a multi-year plan to improve profitability through portfolio optimization, operating expense reductions, and a revamped go-to-market model. Speaking at an investor conference, Willett described industrial machine vision as the technology that enables
Elo Mutual Pension Insurance Co acquired a new stake in shares of Cognex Corporation (NASDAQ: CGNX) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 19,747 shares of the scientific and technical instruments company's stock, valued at approximately $895,000. Other
CGNX pushes AI-driven machine vision and cost cuts, targeting 25-31% through-cycle EBITDA and more than 100% free cash flow conversion in 2026.
The mean of analysts' price targets for Cognex (CGNX) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CGNX leans into AI with its OneVision platform and embedded tools to scale machine vision across logistics and electronics while targeting stronger margins.
Cognex pushes AI-driven machine vision with new products and cloud tools as diversified end markets and a sales overhaul aim to expand adoption and double its customer base.
Cognex Corporation (CGNX) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Fox Run Management L.L.C. purchased a new position in shares of Cognex Corporation (NASDAQ: CGNX) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 48,413 shares of the scientific and technical instruments company's stock, valued at approximately $2,193,000. Cognex makes up
Equitable Trust Co. acquired a new position in shares of Cognex Corporation (NASDAQ: CGNX) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 8,663 shares of the scientific and technical instruments company's stock, valued at approximately $392,000. Other institutional investors also recently
Syon Capital LLC purchased a new stake in Cognex Corporation (NASDAQ: CGNX) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 9,718 shares of the scientific and technical instruments company's stock, valued at approximately $440,000. Other institutional investors and hedge
Director Robert Willett sold 2,148 shares for a total transaction value of approximately ~$128,000 on Feb. 13, 2026. The transaction represented 11.97% of Mr.
Does Cognex Corporation (CGNX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Everyone knows NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and Tesla (NASDAQ:TSLA) are the marquee names in robotics and autonomous systems.